Waltham, MA - Digoxin use is linked to mortality in patients with end-stage renal disease (ESRD), according to the results of a retrospective cohort study reported online June 24, 2010 in the Journal ...
In patients with heart failure with reduced ejection fraction (HFrEF) who have an implantable cardioverter-defibrillator (ICD), the use of digoxin may increase the risk of ventricular tachyarrhythmia ...
NEW ORLEANS, LA—Treating patients with symptomatic rheumatic heart disease (RHD) with digoxin appears to modestly reduce the risk of all-cause mortality or new-onset or worsening heart failure (HF), ...
Digoxin is commonly used in patients with heart failure and atrial fibrillation and is the oldest drug in cardiovascular medicine 1. In 1997, the Digitalis Investigation Group (DIG) trial, a large ...
Heart failure (HF) is the leading cause of hospitalization among older adults. Digoxin has been shown to reduce hospitalization due to worsening HF. However, at the commonly prescribed dose of 0.25 mg ...
Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience new-onset or worsening heart failure during a two-year follow-up compared with ...
The effectiveness and safety of therapeutic interventions are traditionally evaluated with periodic, single time-point assessments. In patients with cardiovascular disease, this often requires ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results